Spironolactone Tablet, Coated
Product Images NDC 72789-292

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72789-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789292 Label (72789292)

72789292 Label (72789292)
Label for Spironolactone Tablets, USP 100 mg, oral coated tablets, containing 90 tablets. Label states each tablet contains Spironolactone USP 100 mg. Distributed by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, LLC, Birmingham, Alabama. Includes storage instructions and barcode with NDC 72789-292.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing probability over months between Spironolactone and placebo groups. The graph shows two lines with Spironolactone group having a higher survival probability than placebo over approximately 42 months, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone to placebo. The subgroups include age, sex, race, LVEF (%), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. The chart visually indicates whether spironolactone or placebo was favored for each subgroup based on HR values.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of the active ingredient spironolactone, depicting its molecular framework with characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.